Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buser

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSPAnthony J Roecker, Paul J Coleman, Swati P Mercer, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitorsShaei Huang, Robert M Garbaccio, Mark E Fraley, et al.
Molecular Cancer Therapeutics|December 14, 2002
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-IRobert B Lobell, Dongming Liu, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2007
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinaseRobert M Garbaccio, Shaei Huang, Edward S Tasber, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2009
Development of thioquinazolinones, allosteric Chk1 kinase inhibitorsAntonella Converso, Timothy Hartingh, Robert M Garbaccio, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSPPaul J Coleman, John D Schreier, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSPAnthony J Roecker, Paul J Coleman, Swati P Mercer, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitorsShaei Huang, Robert M Garbaccio, Mark E Fraley, et al.
Molecular Cancer Therapeutics|December 14, 2002
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-IRobert B Lobell, Dongming Liu, Carolyn A Buser, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2007
Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinaseRobert M Garbaccio, Shaei Huang, Edward S Tasber, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2009
Development of thioquinazolinones, allosteric Chk1 kinase inhibitorsAntonella Converso, Timothy Hartingh, Robert M Garbaccio, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSPPaul J Coleman, John D Schreier, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Cancer Research|December 26, 2001
Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical modelsR B Lobell, C A Omer, M T Abrams, et al.
Pageof 11